-
1
-
-
0029887138
-
The safety and tolerability of venlafaxine hydrochloride: analysis of the clinical trials database
-
Rudolph RL, Derivan AT (1996) The safety and tolerability of venlafaxine hydrochloride: analysis of the clinical trials database. J Clin Psychopharmacol 16(suppl 2): 54S-61S.
-
(1996)
J Clin Psychopharmacol
, vol.16
, Issue.SUPPL. 2
-
-
Rudolph, R.L.1
Derivan, A.T.2
-
3
-
-
0037038983
-
Fatal toxicity of serotinergic and other antidepressant drugs: analysis of UK mortality data
-
Buckley NA, McManus PR (2002) Fatal toxicity of serotinergic and other antidepressant drugs: analysis of UK mortality data. BMJ, Br Med J 325: 1332-1333.
-
(2002)
BMJ, Br Med J
, vol.325
, pp. 1332-1333
-
-
Buckley, N.A.1
McManus, P.R.2
-
4
-
-
14544293989
-
Fatal toxicity of antidepressants in England and Wales, 1993-2002
-
Morgan O, Griffiths C, Baker A, Majeed A (2004) Fatal toxicity of antidepressants in England and Wales, 1993-2002. Health Stat Q 23: 18-24.
-
(2004)
Health Stat Q
, vol.23
, pp. 18-24
-
-
Morgan, O.1
Griffiths, C.2
Baker, A.3
Majeed, A.4
-
5
-
-
0345742559
-
Antidepressant-related deaths and antidepressant prescriptions in England and Wales, 1998-2000
-
Cheeta S, Schifano F, Oyefeso A, Webb L, Ghodse AH (2004) Antidepressant-related deaths and antidepressant prescriptions in England and Wales, 1998-2000. Br J Psychiatry 184: 41-47.
-
(2004)
Br J Psychiatry
, vol.184
, pp. 41-47
-
-
Cheeta, S.1
Schifano, F.2
Oyefeso, A.3
Webb, L.4
Ghodse, A.H.5
-
6
-
-
27744476463
-
Newer antidepressants: evaluation of fatal toxicity index and interaction with alcohol based on Finnish postmortem data
-
Koski A, Vuori E, Ojanperä I (2005) Newer antidepressants: evaluation of fatal toxicity index and interaction with alcohol based on Finnish postmortem data. Int J Legal Med 119: 344-348.
-
(2005)
Int J Legal Med
, vol.119
, pp. 344-348
-
-
Koski, A.1
Vuori, E.2
Ojanperä, I.3
-
7
-
-
33846455086
-
Venlafaxine (Efexor): concerns about increased risk of fatal outcomes in overdose
-
Deshauer D (2007) Venlafaxine (Efexor): concerns about increased risk of fatal outcomes in overdose. Can Med Assoc J 176(1): 39-40.
-
(2007)
Can Med Assoc J
, vol.176
, Issue.1
, pp. 39-40
-
-
Deshauer, D.1
-
8
-
-
0042377403
-
The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicity
-
Dunkley EJ, Isbister GK, Sibbritt D, Dawson AH, Whyte IM (2003) The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicity. Q J Med 96(9): 635-642.
-
(2003)
Q J Med
, vol.96
, Issue.9
, pp. 635-642
-
-
Dunkley, E.J.1
Isbister, G.K.2
Sibbritt, D.3
Dawson, A.H.4
Whyte, I.M.5
-
9
-
-
0011236266
-
-
World Health Organization Collaborating Centre for Drug Statistics Methodology, Oslo: WHO
-
World Health Organization Collaborating Centre for Drug Statistics Methodology (1999) ATC Index with DDDs. WHO, Oslo.
-
(1999)
ATC Index with DDDs
-
-
-
10
-
-
35148890709
-
Drug-induced QT prolongation and torsades de pointes: evaluation of a QT nomogram
-
Chan A, Isbister GK, Kirkpatrick CMJ, Duffull SB (2007) Drug-induced QT prolongation and torsades de pointes: evaluation of a QT nomogram. Q J Med 100(10): 609-615.
-
(2007)
Q J Med
, vol.100
, Issue.10
, pp. 609-615
-
-
Chan, A.1
Isbister, G.K.2
Kirkpatrick, C.M.J.3
Duffull, S.B.4
-
11
-
-
33846868655
-
Risk of suicide during treatment with venlafaxine, citalopram, fluoxetine, and dothiepin: retrospective cohort study
-
Rubino A, Roskell N, Tennis P, Miles D, Weich S, Andrews E (2007) Risk of suicide during treatment with venlafaxine, citalopram, fluoxetine, and dothiepin: retrospective cohort study. BMJ, Br Med J 334: 242-247.
-
(2007)
BMJ, Br Med J
, vol.334
, pp. 242-247
-
-
Rubino, A.1
Roskell, N.2
Tennis, P.3
Miles, D.4
Weich, S.5
Andrews, E.6
-
12
-
-
0037598812
-
Relative toxicity of venlafaxine and selective serotonin reuptake inhibitors in overdose compared to tricyclic antidepressants
-
Whyte IM, Dawson AH, Buckley NA (2003) Relative toxicity of venlafaxine and selective serotonin reuptake inhibitors in overdose compared to tricyclic antidepressants. Q J Med 96: 369-374.
-
(2003)
Q J Med
, vol.96
, pp. 369-374
-
-
Whyte, I.M.1
Dawson, A.H.2
Buckley, N.A.3
-
13
-
-
1842533368
-
Comparative toxicity of citalopram and the newer antidepressants after overdose
-
Kelly CA, Dhaun N, Laing WJ, Strachan FE, Good AM, Bateman DN (2004) Comparative toxicity of citalopram and the newer antidepressants after overdose. J Toxicol, Clin Toxicol 42(1): 67-71.
-
(2004)
J Toxicol, Clin Toxicol
, vol.42
, Issue.1
, pp. 67-71
-
-
Kelly, C.A.1
Dhaun, N.2
Laing, W.J.3
Strachan, F.E.4
Good, A.M.5
Bateman, D.N.6
-
14
-
-
34447303115
-
Cardiovascular toxicity due to venlafaxine poisoning in adults: a review of 235 consecutive cases
-
Howell C, Wilson AD, Waring WS (2007) Cardiovascular toxicity due to venlafaxine poisoning in adults: a review of 235 consecutive cases. BJCP, Br J Clin Pharmacol 64(2): 192-197.
-
(2007)
BJCP, Br J Clin Pharmacol
, vol.64
, Issue.2
, pp. 192-197
-
-
Howell, C.1
Wilson, A.D.2
Waring, W.S.3
-
16
-
-
0032873420
-
Mechanism of sodium channel block by venlafaxine in guinea pig ventricular myocytes
-
Khalifa M, Daleau P, Turgeon J (1999) Mechanism of sodium channel block by venlafaxine in guinea pig ventricular myocytes. J Pharmacol Exp Ther 291(1): 280-284.
-
(1999)
J Pharmacol Exp Ther
, vol.291
, Issue.1
, pp. 280-284
-
-
Khalifa, M.1
Daleau, P.2
Turgeon, J.3
-
17
-
-
33745452416
-
Application of pharmacokineticpharmacodynamic modelling in management of QT abnormalities after citalopram overdose
-
Isbister GK, Friberg LE, Duffull SB (2006) Application of pharmacokineticpharmacodynamic modelling in management of QT abnormalities after citalopram overdose. Intensive Care Med 32: 1060-1065.
-
(2006)
Intensive Care Med
, vol.32
, pp. 1060-1065
-
-
Isbister, G.K.1
Friberg, L.E.2
Duffull, S.B.3
-
18
-
-
0345258011
-
Quetiapine poisoning: a case series
-
Balit C, Isbister G, Hackett L (2003) Quetiapine poisoning: a case series. Emerg Med 42(6): 751-758.
-
(2003)
Emerg Med
, vol.42
, Issue.6
, pp. 751-758
-
-
Balit, C.1
Isbister, G.2
Hackett, L.3
-
19
-
-
0035021986
-
Evaluation of drug-induced QT interval prolongation: implications for drug approval and labelling
-
Malik M, Camm A (2001) Evaluation of drug-induced QT interval prolongation: implications for drug approval and labelling. Drug Safety 24(323): 351.
-
(2001)
Drug Safety
, vol.24
, Issue.323
, pp. 351
-
-
Malik, M.1
Camm, A.2
|